Dr. Chaulagain is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2950 Cleveland Clinic Blvd
Weston, FL 33331Phone+1 954-659-5840Fax+1 954-659-5810
Summary
- I completed clinical and research fellowship in Hematology and Oncology at Tufts University, New England Medical Center in Boston, MA with emphasis in malignant hematology/bone marrow transplantation. I am board certified in Internal Medicine, Medical Oncology, and Hematology. My clinical and research interests and expertise include malignant hematology and more specifically plasma cell diseases such as multiple myeloma and AL amyloidosis.
I also serve on the Board of Directors of the Florida Society of Clinical Oncology (FLASCO) and chair the clinical practice committee of FLASCO. I have been working as a staff hematologist/oncologist in Cleveland clinic since 2014 and currently work as the director of myeloma and amyloidosis program for Cleveland Clinic Florida.
Education & Training
Tufts Medical CenterFellowship, Hematology and Medical Oncology, 2011 - 2014
Cook County Health and Hospitals SystemResidency, Internal Medicine, 2005 - 2008
Tribhuvan University Inst of MedicineClass of 2003
Certifications & Licensure
FL State Medical License 2014 - 2026
MA State Medical License 2011 - 2015
IL State Medical License 2005 - 2011
WI State Medical License 2008 - 2011- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Multiple Myeloma Research Fellow Award Multiple Myeloma Research Foundation (MMRF), 2013
Publications & Presentations
PubMed
- 4 citationsA Synopsis Clonal Hematopoiesis of Indeterminate Potential in Hematology.Maroun Bou Zerdan, Lewis Nasr, Ludovic Saba, Paul Meouchy, Nadine Safi
Cancers. 2022-07-28 - 10 citationsDaratumumab-Based Regimen in Treating Clonal Plasma Cell Neoplasms in Solid Organ Transplant RecipientsChakra P Chaulagain, Julia Diacovo, Leah Elson, Raymond L. Comenzo, Christy J. Samaras
Clinical Lymphoma, Myeloma & Leukemia. 2020-01-08 - 9 citationsManagement of Relapsed-Refractory Multiple Myeloma in the Era of Advanced Therapies: Evidence-Based Recommendations for Routine Clinical Practice.Danai Dima, Fauzia Ullah, Sandra Mazzoni, Louis Williams, Beth Faiman
Cancers. 2023-04-05
Journal Articles
- Clinicopathologic Characteristics of Secondary Squamous Cell Carcinoma of Head and Neck in Survivors of Allogeneic Hematopoietic Stem Cell Transplantation for Hematolo...Kenneth B Miller, Kellie A Sprague, Chakra P Chaulagain, Esha Kaul, Andreas K Klein, Janet Cowan, Nature
Press Mentions
Therapeutic Advancements Help Patients Facing Rare Blood CancerSeptember 28th, 2021- Why Some Myeloma Patients Refuse Stem Cell TransplantDecember 17th, 2023
Professional Memberships
- Member
Other Languages
- Hindi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
